Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a market value of 1.11B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Fundamentals That Matter
It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. […]
Full Post at eglobalist.com